Kabra Drugs Ltd share price logo

Kabra Drugs Ltd Share Price (524322)

₹18.652.41%

as on

| Source : BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Kabra Drugs Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹18.33
    ₹19.49
    downward going graph

    1.72%

    Downside

    4.50%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹8.71
    ₹22.77
    downward going graph

    53.30%

    Downside

    22.09%

    Upside

    downward going graph
Previous Close₹19.11
Open₹19.49
Volume61.36K
Upper Circuit₹20.06
Lower Circuit₹18.16
Day's Low18.33
Day's High19.49
52 Week Low8.71
52 Week High22.77
1 Month Return+ 1.7 %
3 Month Return+ 64.32 %
1 Year Return+ 119.4 %
3 Year Return+ 305.73 %
5 Year Return+ 537 %

Kabra Drugs Ltd Stock Fundamentals & Key Indicators

Check Kabra Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹45.31 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

0.26

P/B Ratio

-2.15

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-9.09

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Kabra Drugs Ltd Stock's Interest Amongst Investors

-34%

Period Aug 22, 2025 to Jul 23, 2025. Change in 30 Days vs previous period

Search interest for Kabra Drugs Ltd Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Kabra Drugs Ltd Financial Results

Get the annual and quarterly financial summary of Kabra Drugs Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

0 (0%)0 (0%)0 (0%)0 (0%)7 (0%)
Net Income

(in ₹ Cr)

-1 (0%)-0 (27%)-1 (35%)0 (172%)-0 (228%)
Net Profit Margin- (0%)- (0%)- (0%)- (0%)-6.99% (0%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

1 (0%)1 (48%)1 (4%)5 (553%)
Total Liabilities

(in ₹ Cr)

2 (0%)1 (30%)1 (28%)3 (144%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-0 (0%)-0 (400%)-0 (48%)-0 (169%)-0 (40%)

Kabra Drugs Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Kabra Drugs Ltd.

  • Kabra Drugs Ltd Earnings Results

    Kabra Drugs Ltd’s net profit jumped 9.09% since last year same period to ₹0.50Cr in the Q1 2025-2026. On a quarterly growth basis, Kabra Drugs Ltd has generated -228.21% fall in its net profits since last 3-months.

    Read More about Earnings Results

Kabra Drugs Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kabra Drugs Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
0%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
100%
0.00
Others
0%
0.00

Kabra Drugs Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Kabra Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA45.31107.4%0.00-1NA
NA144.7017.83%0.847339
NA509.1222.09%0.00NANA
NA732.0831.15%0.514211,280
NA6.03-7.89%0.00-6NA

Insights on Kabra Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, Kabra Drugs stock has moved up by 64.3%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 100.00% of holdings in Jun 2025 quarter

About Kabra Drugs Ltd

Kabra Drugs Ltd was incorporated in 1989 in Indore, Madhya Pradesh and later converted into a Public Limited Company in 1992. The company operates a unit for the manufacturing of Ether derivatives, such as Diethyl Ether Anesthesia Solvent Ether Ethyl Chloride Spray, General Anesthesia and Surgical. Additionally, the company released a range of disinfectants in the market, including hand wash gel, hand sanitizer, and antimicrobial gel, with it being the sole manufacturer of the last.
Kabra Drugs Ltd, has also registered itself as a supplier to the Ministry of Defence, and has designed a variety of new products for the global market. Having acquired experience in producing injectables, soft gelatin capsules, liquids oral and external, especially liquor-based products, the company is now looking to expand its customer base worldwide.

Revenue: ₹7.15Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.50Cr as on June 2025 (Q1 FY26)
OrganisationKabra Drugs Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Kabra Drugs Ltd share price today?

Kabra Drugs Ltd share price today stands at ₹18.65, Open: ₹19.49, Previous Close: ₹19.11, High: ₹19.49, Low: ₹18.33, 52 Week High: ₹22.77, 52 Week Low: ₹8.71 as on .

How to buy Kabra Drugs Ltd shares ?

To buy Kabra Drugs Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524322 or Kabra Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kabra Drugs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Kabra Drugs Ltd?

Today's traded volume of Kabra Drugs Ltd is 61.36K. Which means that 61.36K shares of Kabra Drugs Ltd were bought and sold on the stock market during today's trading session.

What is Kabra Drugs Ltd's market cap today?

Today's market capitalisation of Kabra Drugs Ltd is ₹45.31 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Kabra Drugs Ltd?

Kabra Drugs Ltd’s 52 week high is ₹22.77 and 52 week low is ₹8.71. The current share price of Kabra Drugs Ltd is ₹18.65, which is -18.09% down from its 52 week high and 114.12% up from its 52 week low.